CEO Professor Alan Trounson AO said, “Bringing new cutting-edge technologies such as CLIP-CAR together with Cartherics’ allogeneic NK cell platform is an exciting development that may make these therapies even more effective."
Cartherics enters new collaborative research agreement with TiCARos
April 3, 2024 Australian Biotech
Latest Video
New Stories
-
Targeted blood cancer treatments proposed for funding in New Zealand
February 18, 2026 - - Latest News -
Percheron targets next wave of immunotherapy with novel VISTA checkpoint candidate
February 18, 2026 - - Australian Biotech -
Urgent action needed as antibiotic resistance threatens Australia’s health future
February 17, 2026 - - Latest News -
Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle
February 17, 2026 - - Latest News -
Calls grow for national response to Australia’s worsening medicine shortages
February 17, 2026 - - Latest News -
We do not judge the system on its humanity because we never even discuss it
February 17, 2026 - - Latest News -
PhRMA targets the PBS, urges 'Priority Watch List' inclusion over policy failings
February 17, 2026 - - Latest News

